Science | Nature | Cell | View More
Natural Products
Resibufogenin
Resibufogenin
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Resibufogenin
Price: $118 / 20mg
CAS No.: 465-39-4
Catalog No.: CFN98543
Molecular Formula: C24H32O4
Molecular Weight: 384.51 g/mol
Purity: >=98%
Type of Compound: Steroids
Physical Desc.: Powder
Source: The glandular body of Bufo bufo gargarizans Cantor
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download: COA    MSDS    SDF    Manual
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / $28.7 / In-stock
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • Periyar University (India)
  • Universidad de Antioquia (Colombia)
  • Universidade Federal de Pernamb... (Brazil)
  • Institute of Bioorganic Chemist... (Poland)
  • Auburn University (USA)
  • Celltrion Chemical Research Ins... (Korea)
  • University of Brasilia (Brazil)
  • Guangzhou Institutes of Biomedi... (China)
  • Institute of Pathophysiology Me... (Austria)
  • Centralised Purchases Unit (CPU... (India)
  • Griffith University (Australia)
  • More...
Package
Featured Products
Isovalerylshikonin

Catalog No: CFN95222
CAS No: 52387-14-1
Price: $318/10mg
Benzoylmesaconine

Catalog No: CFN98575
CAS No: 63238-67-5
Price: $168/20mg
Tamarixetin

Catalog No: CFN97027
CAS No: 603-61-2
Price: $ /
Kaempferol 7-O-rhamnoside

Catalog No: CFN96224
CAS No: 20196-89-8
Price: $338/10mg
Isoalantolactone

Catalog No: CFN98107
CAS No: 470-17-7
Price: $40/20mg
Oxypeucedanin hydrate

Catalog No: CFN90557
CAS No: 2643-85-8
Price: $80/20mg
Asimilobine

Catalog No: CFN96772
CAS No: 6871-21-2
Price: $ / mg
Quercetin 3-O-neohesperidoside

Catalog No: CFN91148
CAS No: 32453-36-4
Price: $318/10mg
Vitexin-2''-O-rhamnoside

Catalog No: CFN98177
CAS No: 64820-99-1
Price: $118/20mg
Physalin L

Catalog No: CFN90166
CAS No: 113146-74-0
Price: $288/5mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Resibufogenin is a cytotoxic steroid isolated from the Chinese drug ChanSu, which exhibits the anti-proliferative effect against cancer cells through the degradation of cyclin D1 caused by the activation of GSK-3β. Resibufogenin can inhibit rectifier potassium current ( I K ) and transient potassium current ( I A ), it has pathological effects on central nervous system. Resibufogenin corrects hypertension in a rat model of human preeclampsia, it not only prevents the advent of hypertension and proteinuria, but also the development of intrauterine growth restriction.
Targets: Calcium Channel | Sodium Channel | ATPase | P450 (e.g. CYP17) | GSK-3β
In vivo:
Xenobiotica. 2013 May;43(5):479-85.
Isolation and identification of phase I metabolites of resibufogenin in rats.[Pubmed: 23153055]
1. Resibufogenin (1), a major bufadienolide of Chinese medicine Chan Su, had a wide range of pharmacological activities. In present work, the metabolism of 1 in male Sprague-Dawley rats was investigated by identifying the metabolites of Resibufogenin excreted in rat bile.
METHODS AND RESULTS:
2. Following an oral dose of 60 mg/kg resibufagenin, nine metabolites were isolated from bile of rats, and their structures were identified as 3-keto- Resibufogenin (2), 3-epi-Resibufogenin (3), 5β-hydroxy-3-epi-Resibufogenin (4), 1α, 5β-dihydroxy-3-epi-Resibufogenin (5), 3α, 5β, 14α, 15β-tetrahydroxyl-bufa- 20, 22-dienolide (6), 3α, 14α, 15β-trihydroxy-bufa-20, 22-dienolide (7), 3-epi- 5β-hydroxy-bufalin (8), 12α, 16β-dihydroxy-3-epi-Resibufogenin (9), and 5β, 16β-dihydroxy-3-epi-Resibufogenin (10), respectively, on the basis of widely spectroscopic methods including 2D-NMR technology. It is first time to describe the metabolites of 1 in vivo, and metabolites 5-7 and 9-10 are novel.
CONCLUSIONS:
3. On the basis of these identified metabolites, a possible metabolism pathway for 1 in rats has been proposed. This is the first systematic study on the phase I metabolites of Resibufogenin.
Hypertens Pregnancy. 2010 Jan;29(1):1-9.
Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome.[Pubmed: 19277924 ]
We have developed a rat model of preeclampsia which is based upon excessive volume expansion and includes hypertension, proteinuria and intrauterine growth restriction. In this model, the urinary excretion of the circulating steroid inhibitor of Na +/ K+ ATPase, marinobufagenin, is increased prior to the development of hypertension and proteinuria. An analogue of marinobufagenin, Resibufogenin, successfully treats the hypertension and proteinuria.
METHODS AND RESULTS:
We administered Resibufogenin early in pregnancy in this model, prior to the development of the syndrome. We found that Resibufogenin not only prevented the advent of hypertension and proteinuria, but also the development of intrauterine growth restriction.
CONCLUSIONS:
These results may have relevance to the human condition.
PLoS One . 2015 Jun 29;10(6):e0129851.
Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells[Pubmed: 26121043]
Abstract Huachansu, a traditional Chinese medicine prepared from the dried toad skin, has been used in clinical studies for various cancers in China. Resibufogenin is a component of huachansu and classified as bufadienolides. Resibufogenin has been shown to exhibit the anti-proliferative effect against cancer cells. However, the molecular mechanism of Resibufogenin remains unknown. Here we report that Resibufogenin induces G1-phase arrest with hypophosphorylation of retinoblastoma (RB) protein and down-regulation of cyclin D1 expression in human colon cancer HT-29 cells. Since the down-regulation of cyclin D1 was completely blocked by a proteasome inhibitor MG132, the suppression of cyclin D1 expression by Resibufogenin was considered to be in a proteasome-dependent manner. It is known that glycogen synthase kinase-3β (GSK-3β) induces the proteasomal degradation of cyclin D1. The addition of GSK-3β inhibitor SB216763 inhibited the reduction of cyclin D1 caused by Resibufogenin. These effects on cyclin D1 by Resibufogenin were also observed in human lung cancer A549 cells. These findings suggest that the anti-proliferative effect of Resibufogenin may be attributed to the degradation of cyclin D1 caused by the activation of GSK-3β.
Resibufogenin Description
Source: The glandular body of Bufo bufo gargarizans Cantor
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Epimedin K

Catalog No: CFN95019
CAS No: 174286-13-6
Price: $288/5mg
Pueroside C

Catalog No: CFN95156
CAS No: 112343-16-5
Price: $368/5mg
Alloisoimperatorin

Catalog No: CFN95012
CAS No: 35214-83-6
Price: $338/5mg
Apigenin-8-C-beta-D-glucopyranosyl...

Catalog No: CFN95548
CAS No: N/A
Price: $368/5mg
9-O-Acetyl-fargesol

Catalog No: CFN95031
CAS No: 449172-61-6
Price: $413/5mg
Andrographidine A

Catalog No: CFN95210
CAS No: 113963-37-4
Price: $318/10mg
Methyl 2-hydroxy-3,4-dimethoxybenz...

Catalog No: CFN95383
CAS No: 6395-23-9
Price: $268/5mg
Barbaloin-related compound A

Catalog No: CFN95453
CAS No: 473225-21-7
Price: $318/5mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.6007 mL 13.0036 mL 26.0071 mL 52.0143 mL 65.0178 mL
5 mM 0.5201 mL 2.6007 mL 5.2014 mL 10.4029 mL 13.0036 mL
10 mM 0.2601 mL 1.3004 mL 2.6007 mL 5.2014 mL 6.5018 mL
50 mM 0.052 mL 0.2601 mL 0.5201 mL 1.0403 mL 1.3004 mL
100 mM 0.026 mL 0.13 mL 0.2601 mL 0.5201 mL 0.6502 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Kinase Assay:
Drug Metab Dispos. 2015 Mar;43(3):299-308.
Characterization of phase I metabolism of resibufogenin and evaluation of the metabolic effects on its antitumor activity and toxicity.[Pubmed: 25504504]
Resibufogenin (RB), one of the major active compounds of the traditional Chinese medicine Chansu, has displayed great potential as a chemotherapeutic agent in oncology. However, it is a digoxin-like compound that also exhibits extremely cardiotoxic effects. The present study aimed to characterize the metabolic behaviors of RB in humans as well as to evaluate the metabolic effects on its bioactivity and toxicity. The phase I metabolic profile in human liver microsomes was characterized systemically, and the major metabolite was identified as marinobufagenin (5β-hydroxylResibufogenin, 5-HRB) by liquid chromatography-mass spectrometry and nuclear magnetic imaging techniques.
METHODS AND RESULTS:
Both cytochrome P450 (P450) reaction phenotyping and inhibition assays using P450-selective chemical inhibitors demonstrated that CYP3A4 was mainly involved in RB 5β-hydroxylation with much higher selectivity than CYP3A5. Kinetic characterization demonstrated that RB 5β-hydroxylation in both human liver microsomes and human recombinant CYP3A4 obeyed biphasic kinetics and displayed similar apparent kinetic parameters. Furthermore, 5-HRB could significantly induce cell growth inhibition and apoptosis in A549 and H1299 by facilitating apoptosome assembly and caspase activation. Meanwhile, 5-HRB displayed very weak cytotoxicity of human embryonic lung fibroblasts, and in mice there was a greater tolerance to acute toxicity.
CONCLUSIONS:
In summary, CYP3A4 dominantly mediated 5β-hydroxylation and was found to be a major metabolic pathway of RB in the human liver, whereas its major metabolite (5-HRB) displayed better druglikeness than its parent compound RB. Our findings lay a solid foundation for RB metabolism studies in humans and encourage further research on the bioactive metabolite of RB.
Toxicol In Vitro. 2011 Dec;25(8):1644-53.
Effects of Resibufogenin and Cinobufagin on voltage-gated potassium channels in primary cultures of rat hippocampal neurons.[Pubmed: 21798339]
Outward delayed rectifier potassium channel and outward transient potassium channel have multiple important roles in maintaining the excitability of hippocampal neurons. The present study investigated the effects of two bufadienolides, Resibufogenin (RBG) and Cinobufagin (CBG), on the outward delayed rectifier potassium current (IK) and outward transient potassium current (IA) in rat hippocampal neurons.
METHODS AND RESULTS:
RBG and CBG have similar structures and both were isolated from the venom gland of toad skin. RBG inhibited both IK and IA, whereas CBG inhibited IK without noticeable effect on IA. Moreover, at 1 μM concentration both RBG and CBG could alter some channel kinetics and gating properties of IK, such as steady-state activation and inactivation curves, open probability and time constants.
CONCLUSIONS:
These findings suggested that IK is probably a target of bufadienolides, which may explain the mechanisms of bufadienolides' pathological effects on central nervous system.
Animal Research:
Exp Biol Med (Maywood). 2006 Feb;231(2):215-20.
Resibufogenin corrects hypertension in a rat model of human preeclampsia.[Pubmed: 16446498]
The study of the pathogenesis of preeclampsia has been hampered by a relative dearth of animal models.
METHODS AND RESULTS:
We developed a rat model of preeclampsia in which the excretion of a circulating inhibitor of Na/K ATPase, marinobufagenin (MBG), is elevated. These animals develop hypertension, proteinuria, and intrauterine growth restriction. The administration of a congener of MBG, Resibufogenin (RBG), reduces blood pressure to normal in these animals, as is the case when given to pregnant animals rendered hypertensive by the administration of MBG. Studies of Na/K ATPase inhibition by MBG and RBG reveal that these agents are equally effective as inhibitors of the enzyme.
Isovalerylshikonin

Catalog No: CFN95222
CAS No: 52387-14-1
Price: $318/10mg
Benzoylmesaconine

Catalog No: CFN98575
CAS No: 63238-67-5
Price: $168/20mg
Tamarixetin

Catalog No: CFN97027
CAS No: 603-61-2
Price: $ /
Kaempferol 7-O-rhamnoside

Catalog No: CFN96224
CAS No: 20196-89-8
Price: $338/10mg
Isoalantolactone

Catalog No: CFN98107
CAS No: 470-17-7
Price: $40/20mg
Oxypeucedanin hydrate

Catalog No: CFN90557
CAS No: 2643-85-8
Price: $80/20mg
Asimilobine

Catalog No: CFN96772
CAS No: 6871-21-2
Price: $ / mg
Quercetin 3-O-neohesperidoside

Catalog No: CFN91148
CAS No: 32453-36-4
Price: $318/10mg
Vitexin-2''-O-rhamnoside

Catalog No: CFN98177
CAS No: 64820-99-1
Price: $118/20mg
Physalin L

Catalog No: CFN90166
CAS No: 113146-74-0
Price: $288/5mg
Tags: buy Resibufogenin | Resibufogenin supplier | purchase Resibufogenin | Resibufogenin cost | Resibufogenin manufacturer | order Resibufogenin | Resibufogenin distributor